Hedge Fund - Logos Capital
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q3 (2025-09-30) | $0 | 0% | 0 | $135.50 |
| 2 | 2025 - Q2 (2025-06-30) | $18,853,500 | 2.09% | 150,000 | $114.68 |
| 3 | 2025 - Q1 (2025-03-31) | $0 | 0% | 0 | $126.68 |
| 4 | 2024 - Q4 (2024-12-31) | $27,300,000 | 3.19% | 200,000 | $123.68 |
| 5 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $115.11 |
| 6 | 2023 - Q3 (2023-09-30) | $16,875,000 | 2.25% | 150,000 | $105.30 |
| 7 | 2023 - Q2 (2023-06-30) | $28,290,000 | 3.84% | 300,000 | $97.71 |
| 8 | 2023 - Q1 (2023-03-31) | $20,244,000 | 2.89% | 200,000 | $104.06 |
| 9 | 2022 - Q3 (2022-09-30) | $0 | 0% | 0 | $101.46 |
| 10 | 2022 - Q2 (2022-06-30) | $29,244,000 | 5.36% | 300,000 | $92.29 |
| 11 | 2022 - Q1 (2022-03-31) | $44,531,000 | 5.77% | 475,000 | $84.75 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center